The Ministry of Health, Labor and Welfare is deliberating whether or not to approve using a brand new drug for Alzheimer’s illness collectively developed by Japanese and American pharmaceutical corporations at an skilled subcommittee that simply began.
If authorised, it is going to be the primary time that we will manufacture and promote a drug that instantly acts on and removes the causative agent of Alzheimer’s illness in Japan.
Alzheimer’s illness new drug skilled committee begins deliberation Ministry of Health, Labor and Welfare | NHK
